Cargando…

Implementation of lung cancer screening : proceedings of a workshop /

The public health burden from lung cancer is substantial: it is the second most commonly diagnosed cancer and the leading cause of cancer-related deaths in the United States. Given the individual and population health burden of lung cancer, especially when it is diagnosed at later stages, there has...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Balogh, Erin (rapporteur.)
Autores Corporativos: National Cancer Policy Forum (U.S.) (sponsoring body.), Implementation of Lung Cancer Screening (Workshop)
Otros Autores: Patlak, Margie (rapporteur.), Nass, Sharyl J. (rapporteur.)
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Washington, DC : The National Academies Press, [2017]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn972079088
003 OCoLC
005 20240329122006.0
006 m o d
007 cr un|||||||||
008 170802s2017 dcua obt 000 0 eng
010 |a  2017449060 
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d YDX  |d SCB  |d MMU  |d OCLCF  |d LVT  |d IUL  |d EBLCP  |d MERUC  |d N$T  |d MERER  |d OCLCO  |d OCLCA  |d EZ9  |d NLM  |d OCLCO  |d OCLCQ  |d VT2  |d OCLCQ  |d OCLCO  |d OCLCA  |d G3B  |d IGB  |d STF  |d AU@  |d OCLCQ  |d SFB  |d OCLCO  |d UKAHL  |d OCLCO  |d OCLCA  |d OCLCQ  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |a 101710588  |2 DNLM 
019 |a 992788801  |a 992957941  |a 993069223  |a 1000430219  |a 1021268570  |a 1262677231 
020 |a 9780309451338  |q (electronic bk.) 
020 |a 0309451337  |q (electronic bk.) 
020 |z 9780309451321 
020 |z 0309451329 
029 0 |a NLM  |b 101710588 
035 |a (OCoLC)972079088  |z (OCoLC)992788801  |z (OCoLC)992957941  |z (OCoLC)993069223  |z (OCoLC)1000430219  |z (OCoLC)1021268570  |z (OCoLC)1262677231 
042 |a pcc 
043 |a n-us--- 
050 4 |a RC280.L8 
060 0 0 |a 2018 F-991 
060 1 0 |a WF 658 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.99424  |2 23 
049 |a UAMI 
100 1 |a Balogh, Erin,  |e rapporteur. 
245 1 0 |a Implementation of lung cancer screening :  |b proceedings of a workshop /  |c Erin Balogh, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. 
264 1 |a Washington, DC :  |b The National Academies Press,  |c [2017] 
300 |a 1 online resource (1 PDF file (xxii, 105 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 3 |a The public health burden from lung cancer is substantial: it is the second most commonly diagnosed cancer and the leading cause of cancer-related deaths in the United States. Given the individual and population health burden of lung cancer, especially when it is diagnosed at later stages, there has been a push to develop and implement screening strategies for early detection. However, many factors need to be considered for broad implementation of lung cancer screening in clinical practice. Effective implementation will entail understanding the balance of potential benefits and harms of lung cancer screening, defining and reaching eligible populations, addressing health disparities, and many more considerations. In recognition of the substantial challenges to developing effective lung cancer screening programs in clinical practice, the National Academies of Sciences, Engineering, and Medicine held a workshop in June 2016. At the workshop, experts described the current evidence base for lung cancer screening, the current challenges of implementation, and opportunities to overcome them. Workshop participants also explored capacity and access issues; best practices for screening programs; assessment of patient outcomes, quality, and value in lung cancer screening; and research needs that could improve implementation efforts. This publication summarizes the presentations and discussions from the workshop. 
536 |a This project was supported by Contract No. 200-2011-38807 (Task Order No. 0051) and Contract No. HHSN263201200074I (Task Order No. HHSN26300052) with the Centers for Disease Control and Prevention and the National Cancer Institute/National Institutes of Health, respectively, and by the American Association for Cancer Research, American Cancer Society, American College of Radiology, American Society for Radiation Oncology, American Society of Clinical Oncology, American Society of Hematology, Association of American Cancer Institutes, AstraZeneca, Bristol-Myers Squibb, Cancer Support Community, CEO Roundtable on Cancer, Helsinn Healthcare SA, LIVESTRONG Foundation, National Comprehensive Cancer Network, Novartis Oncology, Oncology Nursing Society, and Pfizer Inc. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. 
588 0 |a Online resource; title from PDF title page (viewed August 26, 2017). 
505 0 |a Pages:1 to 25; Pages:26 to 50; Pages:51 to 75; Pages:76 to 100; Pages:101 to 125; Pages:126 to 129. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Lungs  |x Cancer  |x Treatment  |v Congresses. 
650 1 2 |a Lung Neoplasms  |x diagnosis 
650 1 2 |a Lung Neoplasms  |x epidemiology 
650 2 2 |a Mass Screening 
651 2 |a United States  |x epidemiology 
650 6 |a Poumons  |x Cancer  |x Traitement  |v Congrès. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Lungs  |x Cancer  |x Treatment  |2 fast 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Patlak, Margie,  |e rapporteur. 
700 1 |a Nass, Sharyl J.,  |e rapporteur. 
710 2 |a National Cancer Policy Forum (U.S.),  |e sponsoring body. 
711 2 |a Implementation of Lung Cancer Screening (Workshop)  |d (2016 :  |c Washington, D.C.) 
758 |i has work:  |a Implementation of lung cancer screening (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGQrMDfwFdjRP6kpJ9wYMX  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Implementation of lung cancer screening.  |d National Academies Press, 2017  |z 9780309451321  |w (OCoLC)964380957 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4895145  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36565763 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36618339 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4895145 
938 |a EBSCOhost  |b EBSC  |n 1546474 
938 |a YBP Library Services  |b YANK  |n 14668838 
994 |a 92  |b IZTAP